Vinge has advised Axcel in connection with the investment in XPartners Samhällsbyggnad (“XPartners”), a sustainability-focused technical consulting group, specialising in infrastructure, public and commercial buildings as well as environmental services.

Following Axcel’s investment, the XPartners’ group consists of nine business units employing approximately 400 people across 30 offices in Sweden, generating approximately SEK 600 million in revenue. XPartners is the first investment of Axcel Fund VII.

For more information about the transaction, please see the client’s press release.

Vinge’s team consisted primarily of Christina Kokko, Karl Klackenberg, Carl Fredrik Wachtmeister, Egil Svensson and Elsa Strandberg (M&A), Daniel Prawitz (Construction), Daniel Melander Björner and Tove Hallbäck (Employment), Mikael Ståhl, Seyran Sahin, Karl-Gustaw Tobola and Ida Redander (Financing), Alexandra Tamm (Real Estate), Tove Tullberg and Julia Löfqvist (Compliance), Lisa Hörnqvist (GDPR), Trine Osen Bergqvist, Victoria Fredén and Alva Chambert (ECR) and Emy Rydén (project assistant).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026